414 related articles for article (PubMed ID: 21992498)
21. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic targets of bioactive dietary components for cancer prevention and therapy.
Meeran SM; Ahmed A; Tollefsbol TO
Clin Epigenetics; 2010 Dec; 1(3-4):101-116. PubMed ID: 21258631
[TBL] [Abstract][Full Text] [Related]
23. The clinical application of targeting cancer through histone acetylation and hypomethylation.
Gilbert J; Gore SD; Herman JG; Carducci MA
Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
[TBL] [Abstract][Full Text] [Related]
24. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
25. Diet, epigenetic, and cancer prevention.
Chen J; Xu X
Adv Genet; 2010; 71():237-55. PubMed ID: 20933131
[TBL] [Abstract][Full Text] [Related]
26. Curcumin from Turmeric Rhizome: A Potential Modulator of DNA Methylation Machinery in Breast Cancer Inhibition.
Fabianowska-Majewska K; Kaufman-Szymczyk A; Szymanska-Kolba A; Jakubik J; Majewski G; Lubecka K
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498667
[TBL] [Abstract][Full Text] [Related]
27. The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment.
Basse C; Arock M
Int J Cancer; 2015 Dec; 137(12):2785-94. PubMed ID: 25410431
[TBL] [Abstract][Full Text] [Related]
28. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
29. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
30. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
Park OJ; Surh YJ
Toxicol Lett; 2004 Apr; 150(1):43-56. PubMed ID: 15068824
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic modifications and human pathologies: cancer and CVD.
Duthie SJ
Proc Nutr Soc; 2011 Feb; 70(1):47-56. PubMed ID: 21067630
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
D'Alessio AC; Szyf M
Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
34. Diet and cancer: facts and controversies.
Milner JA
Nutr Cancer; 2006; 56(2):216-24. PubMed ID: 17474868
[TBL] [Abstract][Full Text] [Related]
35. Cancer epigenome.
Lechner M; Boshoff C; Beck S
Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic reprogramming in breast cancer: from new targets to new therapies.
Katz TA; Huang Y; Davidson NE; Jankowitz RC
Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177
[TBL] [Abstract][Full Text] [Related]
37. Vegetables, fruit and phytoestrogens as preventive agents.
Potter JD; Steinmetz K
IARC Sci Publ; 1996; (139):61-90. PubMed ID: 8923020
[TBL] [Abstract][Full Text] [Related]
38. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
39. Approaches to target the genome and its epigenome in cancer.
Chapman-Rothe N; Brown R
Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.
Digel W; Lübbert M
Crit Rev Oncol Hematol; 2005 Jul; 55(1):1-11. PubMed ID: 15886007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
